Skip to main navigation Skip to search Skip to main content

Clinical practice guidelines in Brazil - Developing a national programme

  • Verônica Colpani
  • , Sérgio Candido Kowalski
  • , Airton Tetelbom Stein
  • , Anna Maria Buehler
  • , Daniel Zanetti
  • , Gabriel Côrtes
  • , Edison Vieira De Melo Junior
  • , Jorgiany Emerick Ebeidalla
  • , Natiela Beatriz De Oliveira
  • , Renata Leborato Guerra
  • , Sarah Nascimento Silva
  • , Bruce B. Duncan
  • , Maicon Falavigna
  • , Holger Jens Schünemann
  • Hospital Moinhos de Vento
  • Universidade Federal do Paraná
  • Universidade Federal de Ciências da Saúde de Porto Alegre
  • Hospital Alemão Oswaldo Cruz
  • Ministério da Saúde do Brasil
  • Instituto Nacional de Câncer
  • Universidade Federal do Rio Grande do Sul

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

In Brazil, governmental and non-governmental organisations develop practice guidelines (PGs) in order to optimise patient care. Although important improvements have been made over the past years, many of these documents still lack transparency and methodological rigour. In order to conduct a critical analysis and define future steps in PG development in Brazil, we carried out a structured assessment of strengths, weaknesses, opportunities and threats (SWOT analysis) for the development of a national guideline programme. Participants consisted of academia, methodologists, medical societies and healthcare system representatives. In summary, the PG development process has improved in Brazil and current investments in methodological research and capacity-building are ongoing. Despite the centralised processes for public PGs, standardised procedures for their development are not well established and human resources are insufficient in number and capacity to develop the amount of trustworthy documents needed. Brazil's capacity could be strengthened and initial efforts have been made such as the adoption of standards proposed by world-renowned institutions in PG development and enhancement of the involvement of key stakeholders. Further steps involve the alignment between health technology assessment and PG processes for synergy and the development of a national network to promote the interaction between groups involved in the development of PGs. The lessons learned from this paper could be used to foster debate on guideline development, especially for countries facing similar threats on this topic.

Original languageEnglish
Article number69
JournalHealth Research Policy and Systems
Volume18
Issue number1
DOIs
StatePublished - Jun 17 2020

Keywords

  • Brazil
  • clinical practice
  • evidence-based medicine
  • guideline development

Fingerprint

Dive into the research topics of 'Clinical practice guidelines in Brazil - Developing a national programme'. Together they form a unique fingerprint.

Cite this